Literature DB >> 28578749

Differential prevalence and correlates of whole blood Epstein-Barr virus DNA between HIV-positive and HIV-negative men who have sex with men in Shanghai, China.

R Pan1, X Liu1, S Zhou1, Z Ning2, H Zheng3, M Gao1, Y Ding1, W Yao4, X Liao4, N He1.   

Abstract

This cross-sectional study aimed to examine and compare prevalence and correlates of whole blood Epstein-Barr virus (EBV) DNA between HIV-positive and HIV-negative men who have sex with men (MSM). Five hundred and four HIV-positive MSM and 504 age-matched HIV-negative MSM were recruited from an HIV counseling and testing clinic in Shanghai, China from November 2014 to November 2015 and were administered with a face-to-face questionnaire interview. Whole blood EBV DNA was tested by nested polymerase chain reaction assays on EBNA-1, EBNA-2, and LMP-1 genes. The prevalence of whole blood EBV DNA was 56·0% (95% CI 51·7-60·3%) among HIV-positive MSM and 26·0% (95% CI 22·4-30·0%) among HIV-negative MSM. Whole blood EBV DNA positivity was significantly associated with HIV infection (adjusted odds ratio (aOR) 3·43, 95% CI 2·58-4·57) and frequent intake of pickled, smoked, or salty food (aOR 1·71, 95% CI 1·02-2·86) in the whole sample, and with <200 cells/μl CD4 cell counts (aOR 1·79, 95% CI 1·05-3·05) and pickled, smoked, or salty food intake (aOR 3·14, 95% CI 1·39-7·08) in HIV-positive group. HIV-infected MSM are at higher risk of active EBV replication than HIV-uninfected MSM, underscoring needs of surveillance and research on EBV-related carcinogenesis in this population.

Entities:  

Keywords:  Cancer; EBV; HIV; MSM; risk factors

Mesh:

Substances:

Year:  2017        PMID: 28578749      PMCID: PMC9148847          DOI: 10.1017/S0950268817001054

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  36 in total

1.  Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients.

Authors:  José-Tomás Navarro; Agueda Hernández; Jesús Rodríguez-Manzano; José-Luis Mate; Javier Grau; Mireia Morgades; Elisa Martró; Cristina Tural; Josep-Maria Ribera; Lurdes Matas
Journal:  Med Clin (Barc)       Date:  2010-07-31       Impact factor: 1.725

2.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Authors:  Michael J Silverberg; Bryan Lau; Chad J Achenbach; Yuezhou Jing; Keri N Althoff; Gypsyamber D'Souza; Eric A Engels; Nancy A Hessol; John T Brooks; Ann N Burchell; M John Gill; James J Goedert; Robert Hogg; Michael A Horberg; Gregory D Kirk; Mari M Kitahata; Philip T Korthuis; William C Mathews; Angel Mayor; Sharada P Modur; Sonia Napravnik; Richard M Novak; Pragna Patel; Anita R Rachlis; Timothy R Sterling; James H Willig; Amy C Justice; Richard D Moore; Robert Dubrow
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

3.  Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.

Authors:  C Aitken; S K Sengupta; C Aedes; D J Moss; T B Sculley
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

4.  Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.

Authors:  Xiuchan Guo; Randall C Johnson; Hong Deng; Jian Liao; Li Guan; George W Nelson; Mingzhong Tang; Yuming Zheng; Guy de The; Stephen J O'Brien; Cheryl A Winkler; Yi Zeng
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

Review 5.  Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.

Authors:  Floor Pietersma; Erwan Piriou; Debbie van Baarle
Journal:  Leuk Lymphoma       Date:  2008-06

Review 6.  Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects.

Authors:  Angela Punnett; Richard W Tsang; David C Hodgson
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

7.  Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma.

Authors:  Erwan R Piriou; Karel van Dort; Nening M Nanlohy; Frank Miedema; Marinus H van Oers; Debbie van Baarle
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

Review 8.  Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.

Authors:  M Younas; C Psomas; J Reynes; P Corbeau
Journal:  HIV Med       Date:  2015-10-10       Impact factor: 3.180

9.  Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.

Authors:  Maria Chiara Tisi; Elisa Cupelli; Rosaria Santangelo; Elena Maiolo; Eleonora Alma; Manuela Giachelia; Maurizio Martini; Silvia Bellesi; Francesco D'Alò; Maria Teresa Voso; Maurizio Pompili; Giuseppe Leone; Luigi Maria Larocca; Stefan Hohaus
Journal:  Leuk Lymphoma       Date:  2015-10-12

Review 10.  Reactivation of Epstein-Barr virus from latency.

Authors:  Wolfgang Amon; Paul J Farrell
Journal:  Rev Med Virol       Date:  2005 May-Jun       Impact factor: 6.989

View more
  1 in total

1.  HIV co-infection augments EBV-induced tumorigenesis in vivo.

Authors:  Christopher B Whitehurst; Monica Rizk; Adonay Teklezghi; Rae Ann Spagnuolo; Joseph S Pagano; Angela Wahl
Journal:  Front Virol       Date:  2022-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.